Literature DB >> 11108965

Calcium-dependent translocation of S100A11 requires tubulin filaments.

G E Davey1, P Murmann, M Hoechli, T Tanaka, C W Heizmann.   

Abstract

Protein translocation between different subcellular compartments might play a significant role in various signal transduction pathways. The S100 family is comprised of the multifunctional, small, acidic proteins, some of which translocate in the form of vesicle-like structures upon increase in intracellular Ca(2+) levels. Previously, cells were fixed before and after calcium activation in order to examine the possible relocation of S100 proteins. In this study, we were able to track the real-time translocation. We compared the localization of endogenous S100A11 to that of the S100A11-green fluorescent protein. The application of thapsigargin, an agent increasing intracellular Ca(2+) levels, resulted in the relocation of the S100A11. In contrast, addition of EGTA, which specifically binds Ca(2+), either inhibited the ongoing process of translocation or prevented its induction. Since translocation was not affected by treatment with brefeldin A, it appears that S100A11 relocates in an endoplasmic reticulum-Golgi-independent pathway. Furthermore, the depolymerization of actin filaments by amlexanox did not affect the capacity of S100A11 to translocate. However, the time course treatment with demecolcine, which depolymerizes tubulin filaments, resulted in cease of translocation, suggesting that the tubulin network is required for this process.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11108965     DOI: 10.1016/s0167-4889(00)00098-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization.

Authors:  Luca Fabris; Massimiliano Cadamuro; Lidia Moserle; James Dziura; Xiangyu Cong; Luisa Sambado; Giorgia Nardo; Aurelio Sonzogni; Michele Colledan; Alberto Furlanetto; Nicolò Bassi; Marco Massani; Umberto Cillo; Claudia Mescoli; Stefano Indraccolo; Massimo Rugge; Lajos Okolicsanyi; Mario Strazzabosco
Journal:  Hepatology       Date:  2011-09-02       Impact factor: 17.425

2.  S100 proteins as diagnostic and prognostic markers in colorectal and hepatocellular carcinoma.

Authors:  Claudia Maletzki; Peggy Bodammer; Anne Breitrück; Claus Kerkhoff
Journal:  Hepat Mon       Date:  2012-10-12       Impact factor: 0.660

3.  DNA damage-induced translocation of S100A11 into the nucleus regulates cell proliferation.

Authors:  Theresa Gorsler; Ulrike Murzik; Tobias Ulbricht; Julia Hentschel; Peter Hemmerich; Christian Melle
Journal:  BMC Cell Biol       Date:  2010-12-17       Impact factor: 4.241

4.  Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.

Authors:  Mizuko Tanaka; Naoki Ichikawa-Tomikawa; Namiko Shishito; Keisuke Nishiura; Tomiko Miura; Ayumi Hozumi; Hideki Chiba; Sayaka Yoshida; Tohru Ohtake; Takashi Sugino
Journal:  BMC Cancer       Date:  2015-02-13       Impact factor: 4.430

Review 5.  Evaluating biomarkers in melanoma.

Authors:  Panagiotis Karagiannis; Matthew Fittall; Sophia N Karagiannis
Journal:  Front Oncol       Date:  2015-01-23       Impact factor: 6.244

Review 6.  Role of Biomarkers in the Integrated Management of Melanoma.

Authors:  Piyu Parth Naik
Journal:  Dis Markers       Date:  2021-12-30       Impact factor: 3.434

7.  Targeting Melanoma with Cancer-Killing Viruses.

Authors:  Tiantian Zhang; Yogesh R Suryawanshi; Helene M Woyczesczyk; Karim Essani
Journal:  Open Virol J       Date:  2017-03-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.